Note: Ingredients listed on restricted chemical lists
General Information
Version
01
Product name
RTF 2G
1.2.1 Relevant identified uses
For in vitro diagnostic use
1.2.2. Uses advised against
Other uses are not expected
Manufacturer Name
US/CANADA
Emergency telephone
+44 (0) 3700 492 795, +1 215 ...
Icons in SDS
Company Information
company name
US/CANADA
e-mail address of the competent person responsible for the Safety Data Sheet
infosds@werfen.com
Section 2
SECTION 2: Hazards identification
WHMIS 2015 Classification of the substance or mixture
Other hazards which do not result in classification
None. Warning: The product contains bovine material. All donor animals were sourced from BSE-free herds. The cattle received ante- and post mortem health inspection by a veterinarian, and they were apparently free from infectious and contagious material. However, the material should be treated as potentially infectious. Bovine serum albumin (BSA) might cause allergic skin reaction and/or allergy or asthma symptoms or breathing difficulties if inhaled. 2.5. Unknown acute toxicity No additional information available
2.1 Classification of the substance or mixture
amendment and adjustments Not classified 2.2. Label elements Labelling according to Hazard Communication Standard, 29 CFR 1910.1200 (HCS), and according to Hazardous Product Regulation HPR (WHMIS 2015) and their subsequent amendments and adjustments No labelling applicable 2.3. Hazards associated with known or reasonably anticipated uses No additional information available 2.4. Hazards not otherwise classified Other hazards which do not result in classification : None. Warning: The product contains bovine material. All donor animals were sourced from BSE-free herds. The cattle received ante- and post mortem health inspection by a veterinarian, and they were apparently free from infectious and contagious material. However, the material should be treated as potentially infectious. Bovine serum albumin (BSA) might cause allergic skin reaction and/or allergy or asthma symptoms or breathing difficulties if inhaled. 2.5. Unknown acute toxicity No additional information available SECTION 3 Composition/information on ingredients 3.1. Substances Not applicable 3.2. Mixtures Comments : Composition: lyophilised powder containing inorganic and organic compounds and animal source material. Name Product identifier Conc. % Classification 29 CFR 1910.1200 (HCS) HPR w/w * (WHMIS 2015) Sodium Azide CAS-No.: 26628-22-8 < 0.2 PHNOC 1, PHNOC Acute Toxicity – Oral, cat. 2 Acute Toxicity – Dermal, cat. 1 Acute Toxicity – Inhalation, cat. 2 Specific Target Organ toxicity-Repeated exposure, cat. 2 Aquatic Acute, cat. 1** (M = 1) Aquatic Chronic, cat. 1** (M = 1) Comments : The mixture contains one substance listed in the Hazardous Substance Lists and/or evaluated for carcinogenicity by IARC, NTP, OSHA: Sodium azide. See Section 11 and 15. For exposure limits see Ch. 8. * a range may be indicated, considering batch-to batch variation. **Environmental classification according to Reg. N. 1272/2008 (EC) and subsequent amendments. concentration prior to lyophilization SECTION 4 First-aid measures 4.1. Description of necessary first-aid measures First-aid measures after inhalation : If inhaled, move person to fresh air. If breathing is difficult, oxygen should be administered. Get medical advice if adverse symptoms appear. First-aid measures after skin contact : Remove contaminated clothes and shoes. Wash immediately affected area with soap or mild